Independence Blue Cross

Does Independence Blue Cross cover Wegovy?

Quick answer · Weight Loss

Independence Blue Cross covers Wegovy for weight loss with prior authorization on Employer / Commercial Insurance.

  • Employer / Commercial Insurance: Covered with requirements. BMI of 30 or higher

Source: Pa policy. How we verify this data →

Check your card for your exact plan →

Wegovy for Weight Loss

What Independence Blue Cross requires, by plan type. Open this indication on its own page →

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

  • Age 12 and older
  • BMI of 30 or higher
  • BMI of 27 or higher with a weight-related condition (HTN, CAD, T2DM, dyslipidemia, and OSA)
  • BMI at or above the 95th percentile for age and sex

Qualification pathways

You can qualify through any one of these.

Adult patients (18+) with obesity

All of:

  • Member is 18 years of age or older
  • Documentation (e.g., chart note) confirming BMI >= 30 kg/m2
  • Drug used as adjunct to lifestyle modification
  • No concurrent use of any other GLP-1 receptor agonist (e.g., Ozempic, Rybelsus, Trulicity, Victoza)

Adult patients (18+) with overweight and comorbidity

All of:

  • Member is 18 years of age or older
  • Documentation (e.g., chart note) confirming BMI >= 27 kg/m2
  • One or more comorbidities (e.g., hypertension, coronary artery disease, type 2 diabetes mellitus, dyslipidemia, or obstructive sleep apnea)
  • Drug used as adjunct to lifestyle modification
  • No concurrent use of any other GLP-1 receptor agonist (e.g., Ozempic, Rybelsus, Trulicity, Victoza)

Pediatric patients (12-17 years) with obesity

All of:

  • Member is 12 to 17 years of age
  • Documentation (e.g., chart note) confirming initial BMI at the 95th percentile or greater for age and sex (obesity)
  • Drug used as adjunct to lifestyle modification
  • No concurrent use of any other GLP-1 receptor agonist (e.g., Ozempic, Rybelsus, Trulicity, Victoza)

Documentation to bring

  • Chart note confirming BMI >= 30 kg/m2 OR BMI >= 27 kg/m2 with at least one qualifying comorbidity (adults 18+)
  • Chart note confirming BMI at 95th percentile or greater for age and sex (pediatric patients 12-17)
  • Documentation confirming no concurrent use of another GLP-1 receptor agonist
  • For reauthorization: chart note confirming weight loss >= 5% from baseline body weight

Approval and renewal

  • Initial approval: 6 months
  • Renewal: every 6 months
  • To renew, the plan looks for at least 5% weight loss from the starting weight and Weight loss of >= 5% from baseline body weight required for reauthorization. Concurrent GLP-1 restriction and lifestyle modification adjunct use are re-verified. Initial BMI/comorbidity criteria are NOT re-checked at reauthorization. Make sure your starting weight and date are in the chart now — renewal is measured against it.

Not covered when

  • Personal or family history of medullary thyroid carcinoma (MTC) - contraindication per black box warning
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) - contraindication per black box warning
  • Concurrent use of any other GLP-1 receptor agonist

Policy note: Policy is titled 'Weight Loss Agents' (Rx.01.94). Wegovy is listed only under chronic weight management for weight loss indication in this document. No CV risk reduction, MASH, or other indications are covered in this policy. Pediatric approval (ages 12-17) requires BMI at 95th percentile or greater for age and sex per Cole Criteria. No quantity limits specified in this document. Initial authorization is 7 months; reauthorization is 6 months.

source: Pa policy

Why Wegovy requests get denied by Independence Blue Cross

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Wegovy and Ozempic are the same molecule with different approved uses; a request for Wegovy under a diagnosis that matches Ozempic is routinely denied.
  2. BMI not documented in the chart notes (or documented without a baseline weight and date).
  3. Qualifying weight-related condition not documented with its own diagnosis code.
  4. Baseline weight wasn't recorded at the start, so the required weight loss can't be shown at renewal.

Frequently asked questions

Does Independence Blue Cross cover Wegovy?
Independence Blue Cross covers Wegovy for weight loss with prior authorization on Employer / Commercial Insurance.
What BMI do you need for Wegovy under Independence Blue Cross?
For weight loss on Employer / Commercial Insurance plans, Independence Blue Cross requires a BMI of 30 or higher, or 27 or higher with a qualifying weight-related condition.
How long does a Wegovy approval last with Independence Blue Cross?
Initial approvals last 6 months, and renewals are granted in 6-month periods.
What does Independence Blue Cross require to renew Wegovy?
At least 5% weight loss from the starting weight and Weight loss of >= 5% from baseline body weight required for reauthorization. Concurrent GLP-1 restriction and lifestyle modification adjunct use are re-verified. Initial BMI/comorbidity criteria are NOT re-checked at reauthorization.

Other medications under Independence Blue Cross

Wegovy coverage under other plans

All insurance plans · All medications

This page summarizes Independence Blue Cross's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.